Cancer is a major threat to public health and is still one of the leading causes of death worldwide. Cancer biomarkers are extremely important in the process of early detection of cancer, diagnosis, judgment of the curative effect and the prognosis. They also play an important role in mechanistic research into carcinogenesis. Detection methods based on cancer biomarkers for the determination of cancer can directly affect the diagnosis and treatment. Therefore, the development of highly sensitive and selective approaches for the detection of cancer biomarkers is critical. Micro-and nanoparticles play an important role in the clinical detection of cancer biomarkers. In this review, we provide an overview of the commonly used clinical detection methods for cancer biomarkers, such as enzyme-linked immunosorbent assay, chemiluminescence, electrochemiluminescence, as well as their technical characteristics. Additionally, various applications of recent advances in microparticles and nanoparticles in the clinical detection of cancer biomarkers are also reviewed.
Simple introduction to micro/nanoparticlesMicroparticles and nanoparticles (micro/NPs) are on the micron to nanometer scales and they exhibit several unique characteristics due to their micro-scale effects and large specic surface area. 1 There have been many reports over the last decade about their applications in the disciplines of physics, chemistry, biology, medicine and drugs. [2][3][4] There are many ways to prepare micro/NPs, 5,6 among which chemical synthesis is the most commonly used method in practice. 7,8 Many instrumental analysis methods have been employed for the characterization of micro/nanoparticles, frequently used ones include scanning electron microscopy (SEM), 9,10 scanning tunnelling microscopy (STM), 11 transmission electron microscope (TEM), 12 X-ray diffraction (XRD) test, 13 X-ray photoelectron spectroscopy (XPS) 14 and so on. [15][16][17]
Simple introduction to cancer biomarkersThe most effective way to reduce the threat of cancer is early detection, diagnosis and treatment. Cancer biomarkers (CBs), also known as tumor biomarkers, are excretions or antigens of tumors when they are developing in the organisms. Presently, more than 100 CBs have been discovered and over 30 of them have been used in clinical examination. In clinical utility, several CBs need to be evaluated for the diagnosis of one type of tumor. Some of them are biomarkers for several kinds of tumors. Commonly used CBs include alpha fetoprotein (AFT), carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA153), carbohydrate antigen 199 (CA199). Several methods, such as enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay, microsphere enzyme immunoassay and time-resolved uoroimmunoassay, have been used in practical assays for the detection of CBs. [18][19][20] 3 The role of micro/NPs in bioanalysisThe micro/NPs consistently used in bioanalytical chemistry usually include noble metal NPs (such as gold, silver, etc...